Autism Clinical Trial
Official title:
Environmental Factors in the Etiology of Autism
The purpose of this study is to understand how genes, environment, and the interplay between the two, influences the development of autism and other neurodevelopmental disorders.
The causes and contributing factors for autism are poorly understood. Evidence suggests that
incidence is increasing, but diagnostic changes and improvements may be playing a role. Both
genetic and environmental factors appear to play a role. Autopsy studies demonstrate
structural changes in the brain and clinical investigations reveal neurophysiologic
differences in information processing in autistic versus normal children. Members of our team
recently demonstrated altered levels of certain neuropeptides at birth in children who later
developed autism.
This case-control study is the first large-scale epidemiologic investigation of underlying
causes for autism and triggers of regression. This study capitalizes on the strengths of the
case-control design, which is well suited to examine a broad array of factors for rare
conditions that are thought to be multifactorial. Comparisons will be made with both general
population controls and mentally retarded children.
The aims are to assess the influence of exogenous exposures, the role of susceptibility
factors, and the interplay between these two in the etiology of autism and its phenotypic
variation. Chemicals with known or suspected neurodevelopmental toxicity, such as PCB's,
certain pesticides, and metals, are being investigated. This study pursues several hypotheses
that have recently gained attention, including the combined measles, mumps, rubella vaccine
and mercury present in vaccines given during infancy and early childhood. Additionally,
biochemical susceptibility is examined through characterization of metabolic, immunologic,
and neuronal gene expression profiles and genetic polymorphisms.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05302167 -
Molehill Mountain Feasibility Study.
|
N/A | |
Completed |
NCT04167839 -
Effects of Sensory Diets on Children's Sensory Processing Skills, Psychosocial Skills, and Classroom Engagement
|
N/A | |
Terminated |
NCT04049981 -
Investigation of Mechanisms of Action in Superpower Glass
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT06080087 -
Implementation Toolkit to Enhance EBP Among Marginalized Families
|
N/A | |
Recruiting |
NCT04107064 -
Achieving Steady Work Among Adults With Autism Through Specialized Employment Program
|
N/A | |
Completed |
NCT03206996 -
Exposure Therapy for Auditory Sensitivity in Autism
|
N/A | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Completed |
NCT05588570 -
Coaching Children With Anxiety and Autism Through Telehealth
|
N/A | |
Enrolling by invitation |
NCT06058104 -
Evaluating Efficacy of a Digital Game Therapeutic for Children With Autism
|
N/A | |
Completed |
NCT02911194 -
a2 Milk for Autism and Attention-deficit Hyperactivity Disorder (ADHD)
|
N/A | |
Completed |
NCT03002363 -
The Effects of Video Modeling of Audiological Testing on Pediatric Patient Compliance
|
Phase 1 | |
Completed |
NCT02847182 -
Cord Blood Infusion for Children With Autism Spectrum Disorder
|
Phase 2 | |
Withdrawn |
NCT02414451 -
Trial of Propranolol in Adults and Adolescents With ASD and Predictors of Response
|
N/A | |
Completed |
NCT02508922 -
Trial of Vitamin D3 Supplementation in Paediatric Autism
|
N/A | |
Completed |
NCT02720900 -
Prebiotic Intervention for Autism Spectrum Disorders
|
N/A | |
Completed |
NCT02708290 -
Mental Imagery Therapy for Autism (MITA) - an Early Intervention Computerized Language Training Program for Children With ASD
|
||
Completed |
NCT02536365 -
Sensory Integration Therapy in Autism: Mechanisms and Effectiveness
|
N/A | |
Recruiting |
NCT02255565 -
Dose Response Effects of Quillivant XR in Children With ADHD and Autism: A Pilot Study
|
Phase 4 | |
Recruiting |
NCT01836562 -
A Clinical Trial to Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Autism
|
Phase 1/Phase 2 | |
Completed |
NCT02154828 -
Clinical Evaluation of Integrative Practices Units Infant and Child Care for Unit Children With Typical or Atypical Autism (AUTISM)
|